de Azevedo Mirela J, Dalmáz Caroline A, Caramori Maria Luiza A, Pecis Miriam, Esteves Jorge F, Maia Ana L, Gross Jorge L
Endocrine Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
J Diabetes Complications. 2002 Jul-Aug;16(4):255-62. doi: 10.1016/s1056-8727(01)00185-4.
The aim of this study was to analyze the role of ACE gene insertion/deletion (I/D) and PC-1 gene K121Q polymorphisms in the changes of glomerular filtration rate (GFR), urinary albumin excretion rate (UAER), and blood pressure (BP) levels in a cohort of normoalbuminuric Type 1 diabetic patients. This is a 10.2+/-2.0-year prospective study of 30 normotensive normoalbuminuric Type 1 diabetic patients. UAER (immunoturbidimetry), GFR ((51)Cr-EDTA single injection technique), GHb (ion exchange chromatography), and BP levels were measured at baseline and at 1.7+/-0.6-year intervals. The presence of ACE gene I/D and PC-1 gene K121Q polymorphisms was determined by polymerase chain reaction (PCR) and restriction enzyme techniques. Three patients developed diabetic nephropathy (DN), all carriers of allele D. The presence of allele D was the only predictor (R(2)=.15, F=4.92, P=.035) of the observed GFR decline (-0.29+/-0.34 ml/min/month, P<.05). UAER increased during the study (log UAER=0.0275+/-0.042 microg/min/month, P=.002) and was associated with baseline UAER levels only (R(2)=.17, F=5.72, P=.024). A significant increase (P<.05) in cases of hypertension and retinopathy were observed in ID/DD (n=19) and not in II patients (n=11). Patients with the KQ/QQ genotype (n=8) presented a significant increase (P=.045) in new cases of retinopathy. In conclusion, the presence of the ACE gene D allele in this sample of normoalbuminuric normotensive Type 1 diabetic patients was associated with a higher proportion of microvascular complications and hypertension.
本研究旨在分析血管紧张素转换酶(ACE)基因插入/缺失(I/D)和脯氨酰羧肽酶-1(PC-1)基因K121Q多态性在一组正常白蛋白尿的1型糖尿病患者肾小球滤过率(GFR)、尿白蛋白排泄率(UAER)及血压(BP)水平变化中的作用。这是一项对30例血压正常、尿白蛋白正常的1型糖尿病患者进行的为期10.2±2.0年的前瞻性研究。在基线及每隔1.7±0.6年时测量UAER(免疫比浊法)、GFR((51)Cr-EDTA单次注射技术)、糖化血红蛋白(GHb,离子交换色谱法)及血压水平。采用聚合酶链反应(PCR)和限制性内切酶技术确定ACE基因I/D和PC-1基因K121Q多态性的存在情况。3例患者发生糖尿病肾病(DN),均为D等位基因携带者。D等位基因的存在是观察到的GFR下降(-0.29±0.34 ml/min/月,P<0.05)的唯一预测因素(R²=0.15,F=4.92,P=0.035)。在研究期间UAER升高(log UAER=0.0275±0.042 μg/min/月,P=0.002),且仅与基线UAER水平相关(R²=0.17,F=5.72,P=0.024)。ID/DD组(n=19)高血压和视网膜病变患者显著增加(P<0.05),而II组患者(n=11)则无此现象。KQ/QQ基因型患者(n=8)视网膜病变新发病例显著增加(P=0.045)。总之,在这组正常白蛋白尿、血压正常的1型糖尿病患者样本中,ACE基因D等位基因的存在与较高比例的微血管并发症及高血压相关。